The cost has three parts: one-time costs to list (legal work, PCAOB audits of the parent and often its acquired businesses, SEC filings, market fees and a transfer agent), recurring costs to stay public (quarterly and annual reporting, the annual audit, market fees, investor relations, insurance and a finance team), and costs that never appear on an invoice, chiefly dilution and management time. Figures vary by route and company; PublicFinancial publishes current cost breakdowns for each route. The recurring costs matter most, because they are paid every year and reduce value by your valuation multiple: at 10x, every $100,000 of annual cost removes about $1M of value. My view is that a holding company whose earnings cannot carry these costs comfortably should stay private.
These are paid once, before or at listing. The categories are similar across routes. The size of each depends on the route and on how ready the company is.
For figures by route, see PublicFinancial on direct listing costs and reverse merger costs.
The changes set no fees, but they raise the minimum size of a Nasdaq listing and the cost of a weak share price. As of October 2026:
For a small holding company, these rules make the OTCQB route, with a later uplisting, cheaper to start than a Nasdaq IPO. See Nasdaq's 2026 listing requirements for a small company.
These costs recur every year for as long as the company is listed. They are the ones that decide whether listing pays.
For current figures, see PublicFinancial on the ongoing costs of being public.
Adviser fees often include equity as well as cash. Our Go Public engagement, for example, is a monthly retainer plus equity, set in a proposal, with third-party costs separate. Count any equity paid to advisers as a cost.
Recurring costs are paid out of earnings, and earnings are valued at a multiple. So every recurring dollar costs more than a dollar of value. The $100,000 below is a unit for the arithmetic, not an estimate of your costs.
Now the other side. On the site's illustrative math, $1M of profit bought at 4x ($4M) supports $10M of value inside a platform valued at 10x. If being public is what makes that 10x possible, through stock as currency and access to capital, the recurring cost can be worth paying. If the market values you at a low multiple, it rarely is.
Run this test with your real cost quotes and a low, middle and high trading multiple before you decide.
On timing, this site's working estimate is roughly 6 months by reverse merger or IPO and about 10 months by direct listing. See PublicFinancial on timing.
Where these numbers come from: OTCQB certification and fee guidance are from the OTCQB Rules, version 6.1. Multiples by deal size are GF Data 2024 medians reported by Carry and Conquer. The Nasdaq IPO float rule is from SEC Release 34-102622; the $4 minimum bid filing is SEC Release 34-106614; the $0.10 rule is in the Nasdaq 5800 Series; the $5 million floor and its stay are from SEC Release 34-105971 and SEC Release 34-106594. Castellum figures are from this case review. Stock-paid deal performance is from the study reported on the CLS Blue Sky Blog. Cost figures by route are at PublicFinancial. The 10x multiple and the $100,000 unit are illustrative.
It depends on the company and the route's specific costs, so compare current figures at PublicFinancial. The recurring costs are similar whichever route you take, which is why they matter more.
The OTCQB has lower entry standards than Nasdaq, and as of October 2026 a Nasdaq Capital Market IPO must raise at least $15 million of public float from the offering itself. You still need PCAOB-audited financials, current SEC reporting and an annual CEO and CFO certification, so the core costs remain.
Yes. Shares paid to advisers dilute every other holder. Value them at the price you expect after listing and add them to the cash costs.
A cost that is easy to miss is what listing does to your bank debt: what happens to SBA loans when the parent company goes public?
Meraki Dealmakers is a service of Meraki Partners, LLC, an advisory firm. It is not a broker-dealer, investment adviser, business broker, law firm or accounting firm. This article is general information, not legal, tax or investment advice.
Start with the playbook. The first conversation is free.
Meraki Dealmakers is a service of Meraki Partners, LLC.
Meraki Partners, LLC is an advisory firm. It is not a broker-dealer, investment adviser, business broker, law firm or accounting firm, and does not solicit investors or receive compensation based on capital raised.
© 2026 Meraki Partners, LLC